MyoPax

MyoPax creates advanced regenerative stem cell therapies to combat the devasting effects of muscle illnesses.

Latest funding

Pre Seed · November 4, 2026

Amount not disclosed in a source on record.

Website: myopax.com.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: Biotechnology, Health Care.

Stage: Pre Seed.

Based in: Berlin, Germany.

Last round: Nov 4, 2026 · 8 days ago.

On Recent Funding since: Nov 4, 2026.

Signals

Website registeredMay 29, 2017 (9 years old)

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/myopax (get a free API key).